Outcomes of Minority COVID-19 patients managed with ECMO: A single-center experience.
Can JonesYingyot AroraRenuka ReddyClaudia Tejera QuesadaCristiano FaberVijay NarendranSajid MirzaWaqas GhummanRobert ChaitKai ChenPublished in: Journal of cardiac surgery (2022)
Our cohort revealed a high overall mortality rate of COVID-19 patients on ECMO support. The Caucasian group was observed to have higher mortality than the Minority group. The high overall mortality was likely attributed to the Caucasian group, which had more severe respiratory acidosis before ECMO initiation, a known predictor of poor prognosis in ARDS patients. Our cohort's ethnic composition may also partially explain the high mortality rate since COVID-19 Minorities are reported to have worse outcomes than Caucasians. Larger and randomized studies are needed to investigate further the mortality and complication differences between Minority and Caucasian patients diagnosed with COVID-19 and managed by ECMO.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- sars cov
- poor prognosis
- end stage renal disease
- cardiovascular events
- ejection fraction
- coronavirus disease
- newly diagnosed
- risk factors
- chronic kidney disease
- peritoneal dialysis
- type diabetes
- cardiovascular disease
- mechanical ventilation
- african american
- intensive care unit
- open label
- patient reported outcomes
- insulin resistance
- respiratory syndrome coronavirus
- single cell
- phase iii
- respiratory tract